Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
A rare, genetic disorder of urea cycle metabolism typically characterized by either a severe, neonatal-onset form that manifests with hyperammonemia accompanied with vomiting, hypothermia, lethargy and poor feeding in the first few days of life, or late-onset forms that manifest with stress- or infection-induced episodic hyperammonemia or, in some, behavioral abnormalities and/or learning disabilities, or chronic liver disease. Patients often manifest liver dysfunction.
Sodium phenylbutyrate acts as a chemical chaperone for misfolded ASL proteins while simultaneously providing alternative ammonia disposal through phenylacetylglutamine formation. The compound stabilizes mutant ASL through direct hydrophobic interactions and reduces ER stress by modulating the unfolded protein response via ATF6 pathway inhibition.
Schisandrin B and schisandrin C from Schisandra chinensis berries act as molecular chaperones, stabilizing misfolded argininosuccinate lyase (ASL) through direct binding to hydrophobic regions and reducing ER stress via IRE1α pathway inhibition. These lignans also enhance mitochondrial biogenesis through PGC-1α activation, improving overall cellular energy metabolism in hepatocytes.
Metformin activates AMPK pathway leading to improved mitochondrial biogenesis and enhanced ASL enzyme activity through phosphorylation-dependent conformational changes. L-arginine supplementation provides substrate availability while metformin's anti-inflammatory effects via NF-κB inhibition reduce hepatic inflammation that typically impairs residual ASL function.
Withanolide A and withanoside IV from Ashwagandha root cross the blood-brain barrier and activate Nrf2-ARE pathway, reducing oxidative stress from accumulated argininosuccinic acid. These compounds also modulate GABA-A receptors and reduce neuroinflammation through microglial M2 polarization, protecting against the cognitive impairment associated with chronic hyperammonemia.
Co-administration of silymarin from Silybum marianum (milk thistle) with adeno-associated virus vectors carrying functional ASL genes enhances hepatocyte transduction efficiency through modulation of innate immune responses via TLR4 pathway inhibition. Silymarin also reduces vector-induced inflammation while promoting hepatocyte proliferation through Wnt/β-catenin activation.
Curcumin and demethoxycurcumin activate hepatic nuclear receptors PPARα and PPARγ, upregulating transcription of residual functional ASL genes through direct binding to PPRE sequences in the ASL promoter region. Additionally, these compounds reduce hepatic fibrosis through TGF-β1 pathway inhibition, improving overall liver function and enzyme activity.
Proanthocyanidins and epicatechin from African tamarind fruit pulp scavenge reactive oxygen species generated by accumulated argininosuccinic acid metabolites while activating endogenous antioxidant systems through Keap1-Nrf2 pathway modulation. These compounds also stabilize mitochondrial membrane potential in hepatocytes, preserving cellular ATP production needed for residual ASL function.